Cargando…

Seroprevalence of hepatitis C virus markers in multi-transfused children with beta-thalassemia

Detalles Bibliográficos
Autores principales:	Madhusudhan, Kiran, Thyagarajan, SP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344763/ http://dx.doi.org/10.1186/1471-2334-12-S1-P42

Ejemplares similares

P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Experience of hepatitis C virus seroprevalence and its genomic diversity among transfusion-dependent thalassemia patients in a transfusion center
por: Bhattacharyya, Kallol Kumar, et al.
Publicado: (2018)

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
por: Kuo, K, et al.
Publicado: (2022)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Ocular abnormalities in multi-transfused beta-thalassemia patients
por: Jafari, Reza, et al.
Publicado: (2015)

P1464: CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN GERMANY
por: Udeze, Chuka, et al.
Publicado: (2023)

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients
por: Jang, Tyng-Yuan, et al.
Publicado: (2017)

P1452: MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN ITALY
por: Udeze, Chuka, et al.
Publicado: (2023)

5588005 IMPACT OF COVID-19 PANDEMIC TO PRE-TRANSFUSION HEMOGLOBIN LEVEL AND FREQUENCY OF TRANSFUSION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS IN INDONESIA
por: Dewi, M.K.D., et al.
Publicado: (2023)

Seroprevalence of hepatitis B, hepatitis C and HIV in ICU patients
por: Bayir, H, et al.
Publicado: (2015)

Beta thalassemia prevention in India: evaluation of socio- cultural factors
por: Chawla, Swati, et al.
Publicado: (2014)

Hepatitis E virus seroprevalence in patients with HIV in Nizhny Novgorod, Russia
por: Sharipova, IN, et al.
Publicado: (2014)

Hepatitis E virus prevalence in Egyptian children with transfusion-dependent thalassemia
por: Abdelmawla, Doaa, et al.
Publicado: (2019)

Seroprevalence of HBV, HCV and HIV-1 and Correlation with Molecular Markers among Multi-Transfused Thalassemia Patients in Western India
por: Mishra, Kanchan, et al.
Publicado: (2020)

P-083: IMPACT OF ALPHA THALASSEMIA COEXISTENCE ON TRANSFUSION NEED AMONG PATIENTS WITH SICKLE CELL DISEASE
por: A., MADRUGA DE OLIVEIRA LAGROTTA PITTELLA, et al.
Publicado: (2022)

5613475 ADVERSE REACTIONS TO RBC TRANSFUSION: A SINGLE THALASSEMIA AND SICKLE CELL DISEASE DEPARTMENT’S EXPERIENCE
por: Xydaki, A.X., et al.
Publicado: (2023)

Diabetic mellitus type 1 in patient with beta major thalassemia (case report)
por: Intan, Eka, et al.
Publicado: (2013)

Seroprevalence of transfusion transmissible viral infections among blood donors in a tertiary care hospital
por: Kumar, C Dhinesh, et al.
Publicado: (2012)

P1742: SYSTEMATIC LITERATURE REVIEW OF THE BURDEN OF ILLNESS AND OUTCOME ANALYSES OF PATIENTS WITH NON-TRANSFUSION DEPENDENT BETA-THALASSEMIA
por: Aydinok, Y., et al.
Publicado: (2022)

P1462: NEUROCOGNITIVE FUNCTION AND PSYCHOLOGICAL ASSESSMENT IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS: RELATION TO BRAIN IRON CONTENT
por: Adly, Amira, et al.
Publicado: (2023)

The transfusion management of beta thalassemia in the United States
por: Lal, Ashutosh, et al.
Publicado: (2021)

5574716 PROBLEMS AND STRATEGIES OF BLOOD TRANSFUSION IN THALASSEMIA DURING COVID-19 PANDEMIC IN INDONESIA
por: Rahmartani, L.D.R., et al.
Publicado: (2023)

5613391 SUBCLINICAL NEPHROTOXICITY IN PATIENTS WITH BETA-THALASSEMIA: ROLE OF URINARY KIDNEY INJURY MOLECULE
por: Zakaria, M., et al.
Publicado: (2023)

P1508: LUSPATERCEPT REDUCES THE BURDEN OF RED BLOOD CELL TRANSFUSION IN PATIENTS WITH BETA -THALASSEMIA AND COMORBIDITIES: THE EXPERIENCE OF A SINGLE THALASSEMIA AND SICKLE CELL UNIT IN A UNIVERSITY HOSPITAL
por: Delicou, S., et al.
Publicado: (2022)

5588571 DYSLIPIDEMIA IN TRANSFUSION-DEPENDENT-THALASSEMIA PATIENTS AND ITS CORRELATION WITH SERUM VITAMIN D LEVEL
por: El-Ghamrawy, M., et al.
Publicado: (2023)

Feasibility of stored red blood cell transfusion in pigs
por: Azevedo, LCP, et al.
Publicado: (2009)

Non-transfusion dependent hemoglobin E/β thalassemia had high prevalence of vitamin D deficiency than more severe patients who received regular blood transfusion and iron chelation therapy
por: Nakavachara, Pairunyar, et al.
Publicado: (2013)

Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran
por: Farshadpour, Fatemeh, et al.
Publicado: (2022)

P-054: EVALUATION OF FIRST MICROCHIP-BASED POINT-OF-CARE DEVICE FOR DIAGNOSIS OF BETA-THALASSEMIA IN INDIA
por: A., MEHTA, et al.
Publicado: (2022)

5613312 PLASMATIC MICROPARTICLES AS POTENTIAL BIOMARKERS IN THE PREVENTIVE DIAGNOSIS OF BETA THALASSEMIA
por: Chebbi, M., et al.
Publicado: (2023)

Endocrinopathies in Thalassemia major patients in Thalassemia Center Jakarta, Indonesia
por: Soesanti, Frida, et al.
Publicado: (2013)

Frequency of Hepatitis B, C and HIV Infections among Transfusion-Dependent Beta Thalassemia Patients in Dhaka
por: Bhuyan, Golam Sarower, et al.
Publicado: (2021)

5610611 REAL-WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS
por: Musallam, K.M., et al.
Publicado: (2023)

Mutational analysis of thalassemia in transfusion-dependent beta-thalassemia patients from central India
por: Shrivastava, Manisha, et al.
Publicado: (2019)

P1522: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
por: Kuo, K. H. M., et al.
Publicado: (2022)

5613374 ASSOCIATION BETWEEN GENOTYPE AND DISEASE COMPLICATIONS IN EGYPTIAN PATIENTS WITH BETA THALASSEMIA
por: Hassan, T.H., et al.
Publicado: (2023)

Seroprevalence of Hepatitis B-surface antigen among selected group of population
por: Karim, Rezaul
Publicado: (2010)

Community genetics approaches in the prevention of beta-thalassemia: towards achieving ‘Zero beta-thalassemia’ status in India
por: Rao, V R
Publicado: (2014)

P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA: EVIDENCE FOR IRON SHUTTLING TO TRANSFERRIN—RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (START)
por: Tricta, F., et al.
Publicado: (2022)

Diffuse Hepatic Calcifications in a Transfusion-Dependent Patient with Beta-Thalassemia: A Case Report
por: Saki, Forough, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nr9hibun4e2nshvbp2p74arne8